Measures autoantibodies against the La (SS-B) protein, used to help diagnose Sjögren's syndrome and other connective tissue diseases.
AK gg SS-B (La) (ENA) is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
AK gg SS-B (La) (ENA) becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
AK gg SS-B (La) (ENA) does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Anti-SS-B (La) antibodies are autoantibodies that target the La protein, which is involved in processing RNA in the cell nucleus. They are part of the extractable nuclear antigen (ENA) panel and are primarily tested when autoimmune conditions such as Sjögren's syndrome or systemic lupus erythematosus are suspected. The test is performed on a blood sample and detects the presence of these antibodies. A positive result indicates an immune reaction against the body's own tissues, and it is often evaluated together with anti-SS-A (Ro) antibodies.
A negative result (usually defined as below the lab's cutoff value) means no anti-SS-B antibodies were detected. This is considered normal and suggests a lower likelihood of Sjögren's syndrome or related autoimmune diseases. However, it does not entirely exclude the possibility, as antibody levels can be very low early in the disease or during remission.
A positive result indicates the presence of anti-SS-B antibodies above the cutoff. This is strongly associated with Sjögren's syndrome but can also occur in systemic lupus erythematosus and other rheumatic conditions. The result is usually reported as positive/negative, though some labs may provide a titer. Clinical interpretation requires correlation with symptoms and other laboratory findings.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
AK gg SS-B (La) (ENA) becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Anti-SS-B (La) Antibodies (ENA) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
It is primarily used to help diagnose Sjögren's syndrome, particularly when a person has symptoms like dry eyes and dry mouth. It is often ordered alongside the anti-SS-A (Ro) antibody test and other autoimmune markers.
A positive result means your immune system has produced antibodies against the La protein. It is commonly seen in Sjögren's syndrome but can also appear in systemic lupus erythematosus and some other autoimmune diseases. Your doctor will consider this result together with your symptoms and other tests.
No. While anti-SS-B antibodies are a specific marker, not everyone with Sjögren's syndrome tests positive. Some patients may only have anti-SS-A antibodies, or both may be negative. Diagnosis often requires a combination of clinical signs, other blood tests, and sometimes a lip biopsy.
AK gg SS-B (La) (ENA) does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
AK gg SS-B (La) (ENA) is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
